<DOC>
	<DOCNO>NCT00857779</DOCNO>
	<brief_summary>The aim study test pharmacodynamic equivalence respect IgE-blocking factor compare tolerability two different updosing schedule ALK-Flex SQ</brief_summary>
	<brief_title>Study Pharmacodynamic Parameter Tolerability With Subcutaneous Immunotherapy Grass Pollen Allergic Patients</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>A clinical history grass pollen induce allergic rhinoconjunctivitis two year require treatment grass pollen season Lack adequate relief symptomatic medication previous grass pollen season Positive Skin Prick Test ( SPT ) response Phleum pratense ( wheal diameter &gt; = 3mm ) currently perform old 60 day screen FEV1 &lt; 70 % predict value screen Bronchial asthma correspond GINA step 3 , even control History asthma exacerbation emergency visit admission asthma previous 12 month Previous treatment immunotherapy grass pollen allergen allergen within previous 5 year Exclusion criterion accordance contraindication SPC ALKFlex SQ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>allergen immunotherapy</keyword>
	<keyword>allergy grass pollen</keyword>
</DOC>